Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015

Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor–Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease

(2018) Wan-Ju Lee et al.   INFLAMMATORY BOWEL DISEASES

Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions

(2018) Gregory S. Calip et al.   INTERNATIONAL JOURNAL OF CANCER

Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates

(2018) Hau-Jyun Su et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study

(2017) Christopher Alexakis et al.   INFLAMMATORY BOWEL DISEASES

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

(2017) Magali Lemaitre et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials

(2017) Zheng Zhang et al.   BMJ Open

Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea

(2016) S. N. Hong et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

(2016) E. J. Mao et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use

(2016) E. Guirao-Arrabal et al.   Transplant Infectious Disease

PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation

(2015) Kyle Dammann et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Infection risk associated with anti-TNF-α agents: a review

(2015) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

(2015) Aparna Schweitzer et al.   LANCET

Biologic agents for IBD: practical insights

(2015) Silvio Danese et al.   Nature Reviews Gastroenterology & Hepatology

Immunopathogenesis of IBD: current state of the art

(2015) Heitor S. P. de Souza et al.   Nature Reviews Gastroenterology & Hepatology

Peroxisome Proliferator-Activated Receptors Family Is Involved in the Response to Treatment and Mild Clinical Course in Patients with Ulcerative Colitis

(2014) J. K. Yamamoto-Furusho et al.   DISEASE MARKERS

The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead

(2014) Aleksandar D. Kostic et al.   GASTROENTEROLOGY

The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ

(2013) Christel Rousseaux et al.   CARCINOGENESIS

Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)

(2013) Fernando Magro et al.   Journal of Crohns & Colitis

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations

(2012) Gert Van Assche et al.   Journal of Crohns & Colitis

Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review

(2012) Kavitha Subramaniam et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Long-term follow-up of ulcerative colitis in Taiwan

(2012) Shu-Chen Wei et al.   Journal of the Chinese Medical Association

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Safety

(2011) Gert Van Assche et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases

(2011) Benoit Chassaing et al.   GASTROENTEROLOGY

Genetics and pathogenesis of inflammatory bowel disease

(2011) Bernard Khor et al.   NATURE

Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy

(2011) María Luisa Manzano-Alonso   WORLD JOURNAL OF GASTROENTEROLOGY

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

(2010) A. Dignass et al.   Journal of Crohns & Colitis

A Comprehensive Review of the Adverse Effects of Systemic Corticosteroids

(2010) David M. Poetker et al.   OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA

Long-term Follow-up of Ulcerative Colitis in the Chinese Population

(2009) Dorothy K L Chow et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevalence of ulcerative colitis and Crohn’s disease in Japan

(2009) Keiko Asakura et al.   JOURNAL OF GASTROENTEROLOGY

An Update on the Epidemiology of Inflammatory Bowel Disease in Asia

(2008) Kelvin T. Thia et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: A KASID study

(2007) Suk-Kyun Yang et al.   INFLAMMATORY BOWEL DISEASES